|
Douglas E. Williams Ph.D. joined our Board of Directors in August 2004. Dr. Williams currently serves as President and Chief Scientific Officer of ZymoGenetics Inc. Prior to joining ZymoGenetics Dr. Williams served as Chief Scientific Officer and Executive Vice President Research and Development of Seattle Genetics. Previously he served as Senior Vice President Washington Site Leader and member of the Executive Committee for Amgen Inc. following Amgen's acquisition of Immunex Corp. where he served from 1988 to 2002 most recently as Executive Vice President Chief Technology Officer and a member of Immunex's Board of Directors. Dr. Williams currently serves on the Board of Directors of Array Biopharma and Aerovance Inc. He is also a member of the Scientific Advisory Board of Symphony Capital in New York. Dr. Williams holds a B.S. magna cum laude in Biological Sciences from the University of Massachusetts Lowell and a Ph.D. in Physiology from the State University of New York at Buffalo Roswell Park Division. | 